4 sources checked · 2 source groups included · 35m ago
Still Watching
Ozempic, Wegovy users sue over rare, permanent blindness
Over 200 federal lawsuits allege GLP-1 drugs like Ozempic and Mounjaro caused NAION, a rare permanent vision loss condition, with manufacturers disputing the claims.
1 Left3 Center0 Right
Still watching.Optics is waiting for a cleaner match before calling the split.
STILL WATCHING
As of September 26, 2026 at 10:00 AM, this is how Optics News reads the wording differences in this story.
What happenedOver 200 federal lawsuits allege GLP-1 drugs like Ozempic and Mounjaro caused NAION, a rare permanent vision loss condition, with manufacturers disputing the claims.
The headline splitThe headlines are mostly aligned. The differences are small wording choices, not a major framing split.
Match confidenceMedium confidence. 4 sources across 2 bias buckets. Useful framing signal — check the source list before sharing.
Same-event confidenceMedium
4 sources across 2 bias buckets agree on the event.
Framing confidenceMostly same
0/99 — the outlets mostly agree on the headline takeaway.
WHAT EACH SIDE EMPHASIZED
Left / center-leftOzempic, Wegovy users sue over rare, permanent blindness
The Plain Dealer Cleveland · Center-left · News report
CenterOzempic, Wegovy users sue over rare, permanent blindness
The Star-Ledger (NJ.com) · Center · News report
Right / center-rightNo matching source in this bucket yet.
Ozempic, Wegovy users sue over rare, permanent blindness
Over 200 federal lawsuits allege GLP-1 drugs like Ozempic and Mounjaro caused NAION, a rare permanent vision loss condition, with manufacturers disputing the claims.
Ozempic, Wegovy users sue over rare, permanent blindness
Over 200 federal lawsuits allege GLP-1 drugs like Ozempic and Mounjaro caused NAION, a rare permanent vision loss condition, with manufacturers disputing the claims.
Ozempic, Wegovy users sue over rare, permanent blindness
Over 200 federal lawsuits allege GLP-1 drugs like Ozempic and Mounjaro caused NAION, a rare permanent vision loss condition, with manufacturers disputing the claims.
Ozempic, Wegovy users sue over rare, permanent blindness
Over 200 federal lawsuits allege GLP-1 drugs like Ozempic and Mounjaro caused NAION, a rare permanent vision loss condition, with manufacturers disputing the claims.
